Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure by rss feed | May 5, 2021 | News Feeds Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures. Read Original Copy